EASL Policy Dialogues - EASL’s statement: Key asks to the EU for the Liver

In April 2024, EASL released a statement to reiterate evidence-based recommendations to the European Union Institutions for the next political term, to address boldly the human and financial burden of liver disease in Europe. Policy makers can no longer ignore the enormous impact on millions of lives across Europe, and on health budgets in every country.
The EASL Policy Dialogues Season 3 is supported by Novo Nordisk. EASL has received no input from Novo Nordisk with regards to the content of the EASL Policy Dialogues Season 3.